Protara Therapeutics Inc
Protara Therapeutics Inc (TARA) Option Chain
As of September 25, 2026, Protara Therapeutics Inc is trading at $3.28, a -2.09% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 77.4%. IV Rank is 9%.
Read more
Tracking the TARA option chain helps you see every strike and expiry on Protara Therapeutics Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Protara Therapeutics Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of TARA options activity at a glance. Use our scanner to monitor the TARA option chain in real time and filter for the TARA options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For TARA stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the TARA option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where TARA stock options are being actively traded and where they are not.
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. The company was formerly known as ArTara Therapeutics, Inc. and changed its name to Protara Therapeutics, Inc. in May 2020.
Protara Therapeutics, Inc. is headquartered in New York, New York.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Protara Therapeutics Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen TARA options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of TARA stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile29.37% Subdued
- Market cap (M$)194
- 52 weeks high-58.06%
- 52 weeks low-1.20%
- Analyst recommendationStrong Buy
1.00 - Target price$25.71
683.84% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-09
- P/E—
- Future P/E—
- EPS (ttm)-1.35
- EPS growth next 5 years23.07%
As of September 25, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 7.22 | 1 | 0 | 0.22 | 0.78 | 0.40 | 1.60 | 2.50 | -25.37 | — | 0.30 | 0.00 | 0.30 | 0 | 0 | 92.78 |
| 98.58 | 125 | 0 | 0.20 | 0.00 | — | 0.20 | 5.00 | +49.25 | 0.95 | 2.20 | 1.72 | -0.15 | 6 | 30 | 1.42 |
| 100.00 | 0 | 0 | 0.75 | 0.00 | — | 0.75 | 7.50 | +123.88 | 3.30 | 4.70 | 4.22 | -0.22 | 0 | 0 | 0.00 |
As of September 25, 2026
Scan the full option chain in one place
Browse the full TARA option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→